Two Covid vaccination doses aren’t ‘enough for omicron,’ according to Pfizer’s CEO
On Monday, Pfizer CEO Albert Bourla indicated that two doses of the company’s vaccine may not provide adequate protection against infection by the omicron Covid form, and that the initial shots have lost part of their efficacy in avoiding hospitalisation. Bourla stressed the importance of a third shot to increase people’s protection against omicron in…